QT Imaging Holdings, Inc.(QTI)

Medical - Devices · Novato, CA

$2.58-0.03 (-1.15%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T21:08:13.685Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:08:13.685Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 35,523,770
TTM operating cash flow · period ending 2026-06-30: -12,471,178

FMP input reference: 73a05a26affbff61ca245286eab2f65fbc602d03c7bc752639a64992bef0efba

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

QTI Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

QTI Competitors' Price/OCF Ratio

QTI

QT Imaging Holdings, Inc.

Current

Market Cap

$35.52M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs QTI

Market Cap

$35.76M

Price/OCF Ratio

N/A

TTM Avg

2.00

3Y Avg

3.35

5Y Avg

33.77

EDSA

Edesa Biotech, Inc.

vs QTI

Market Cap

$35.84M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs QTI

Market Cap

$35.84M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs QTI

Market Cap

$34.97M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs QTI

Market Cap

$36.21M

Price/OCF Ratio

N/A

TTM Avg

503.18

3Y Avg

503.18

5Y Avg

503.18

ELUT

Elutia Inc

vs QTI

Market Cap

$34.35M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCLX

Scilex Holding Company

vs QTI

Market Cap

$33.63M

Price/OCF Ratio

N/A

TTM Avg

5.50

3Y Avg

5.64

5Y Avg

5.64

GRCE

Grace Therapeutics, Inc.

vs QTI

Market Cap

$33.61M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs QTI

Market Cap

$33.29M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
QT Imaging Holdings, Inc. (QTI)	$35.52M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.76M	N/A	2.00	3.35	33.77
Edesa Biotech, Inc. (EDSA)vs ›	$35.84M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$35.84M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$34.97M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$36.21M	N/A	503.18	503.18	503.18
Elutia Inc (ELUT)vs ›	$34.35M	N/A	N/A	N/A	N/A
Scilex Holding Company (SCLX)vs ›	$33.63M	N/A	5.50	5.64	5.64
Grace Therapeutics, Inc. (GRCE)vs ›	$33.61M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.29M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

QTI Price/OCF Ratio Metrics

QTI Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics